Alternate mRNA processing of the hepatocyte nuclear factor genes and its role in monogenic diabetes

References

• Boj SF, Parrizas M, Maestro MA, Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc. Natl Acad. Sci. USA98(25), 14481–14486 (2001).
   PubMed Web of Science ®Google Scholar
• Ferrer J. A genetic switch in pancreatic β-cells: implications for differentiation and haploinsufficiency. Diabetes51(8), 2355–2362 (2002).
   PubMed Web of Science ®Google Scholar
• Odom DT, Dowell R, Jacobson E et al. Core transcriptional regulatory circuitry in human hepatocytes. Mol. Syst. Biol.2, E1–E5 (2006).
   Google Scholar
• Owen K, Hattersley AT. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract. Res.Clin. Endocrinol. Metab.15(3), 309–323 (2001).
   Web of Science ®Google Scholar
• Vaxillaire M, Froguel P. Genetic basis of maturity-onset diabetes of the young. Endocrinol. Metab. Clin. North Am.35(2), 371–384 (2006).
   Google Scholar
• Velho G, Robert J. Maturity-onset diabetes of the young (MODY): genetic and clinical characteristics. Horm. Res.57(Suppl. 1), 29–33 (2002).
   PubMedGoogle Scholar
• Frayling T, Bulman MP, Ellard S et al. Mutations in the hepatocyte nuclear factor 1α gene are a common cause of maturity-onset diabetes of the young in the United Kingdom. Diabetes46, 720–725 (1997).
   PubMed Web of Science ®Google Scholar
• Weedon MN, Owen KR, Shields B et al. Common variants of the hepatocyte nuclear factor-4α P2 promoter are associated with type 2 diabetes in the U.K. population. Diabetes53(11), 3002–3006 (2004).
   Google Scholar
• Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B. The hepatic nuclear factor-1α G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J. Clin. Endocrinol. Metab.84(3), 1077–1082 (1999).
   PubMed Web of Science ®Google Scholar
• Johnson JM, Castle J, Garrett-Engele P et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science302(5653), 2141–2144 (2003).
   PubMed Web of Science ®Google Scholar
• Modrek B, Lee C. A genomic view of alternative splicing. Nat. Genet.30(1), 13–19 (2002).
   PubMed Web of Science ®Google Scholar
• Drewes T, Senkel S, Holewa B, Ryffel GU. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol. Cell. Biol.16(3), 925–931 (1996).
   PubMed Web of Science ®Google Scholar
• Stamm S, Ben-Ari S, Rafalska I et al. Function of alternative splicing. Gene344, 1–20 (2005).
   PubMed Web of Science ®Google Scholar
• Akker SA, Smith PJ, Chew SL. Nuclear post-transcriptional control of gene expression. J. Mol. Endocrinol.27(2), 123–131 (2001).
   Google Scholar
• Schulte PM. Changes in gene expression as biochemical adaptations to environmental change: a tribute to Peter Hochachka. Comp. Biochem. Physiol. B. Biochem Mol. Biol.139(3), 519–529 (2004).
   Google Scholar
• Poly WJ. Nongenetic variation, genetic-environmental interactions and altered gene expression. I. Temperature, photoperiod, diet, pH and sex-related effects. Comp. Biochem. Physiol. A. Physiol.117(1), 11–66 (1997).
   Google Scholar
• Tao H, Szeszel-Fedorowicz W, Amir-Ahmady B, Gibson MA, Stabile LP, Salati LM. Inhibition of the splicing of glucose-6-phosphate dehydrogenase precursor mRNA by polyunsaturated fatty acids. J. Biol. Chem.277(34), 31270–31278 (2002).
   PubMed Web of Science ®Google Scholar
• Cereghini S, Ott MO, Power S, Maury M. Expression patterns of vHNF1 and HNF1 homeoproteins in early postimplantation embryos suggest distinct and sequential developmental roles. Development116(3), 783–797 (1992).
   PubMed Web of Science ®Google Scholar
• Poll A, Pierreux CE, Lokmane L et al. A vHNF1/TCF2-HNF6 cascade regulates the transcription factor network that controls generation of pancreatic precursor cells. Diabetes55(1), 61–69 (2006).
   PubMed Web of Science ®Google Scholar
• Vaxillaire M, Abderrahmani A, Boutin P et al. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J. Biol. Chem.274(50), 35639–35646 (1999).
   Google Scholar
• Ryffel GU. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J. Mol. Endocrinol.27(1), 11–29 (2001).
   PubMed Web of Science ®Google Scholar
• Bach I, Yaniv M. More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA preocessing. EMBO J.12(11), 4229–4242 (1993).
   Google Scholar
• Bjorkhaug L, Njolstad P, Thorsby P et al. Molecular genetic analyses of Norwegian families with maturity-onset diabetes of the young. Diabetologia48(Suppl. 1), A115 (Abstract 422) (1999).
   Google Scholar
• Chouard T, Jeannequin O, Rey-Campos J, Yaniv M, Traincard F. A set of polyclonal and monoclonal antibodies reveals major differences in post-translational modification of the rat HNF1 and vHNF1 homeoproteins. Biochimie79(12), 707–715 (1997).
   PubMedGoogle Scholar
• Carriere V, Lascasa M, Rousset M. Activity of hepatocyte nuclear factor 1α and hepatocyte nuclear factor 1β isoforms is differently affected by the inhibition of protein phosphatases 1/2A. Biochem. J.354, 301–308 (2001).
   Google Scholar
• Harries L, Ellard S, Stride A, Morgan N, Hattersley A. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1α show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum. Mol. Genet.15(14), 2216–2224 (2006).
   PubMed Web of Science ®Google Scholar
• Ringeisen F, Rey-Campos J, Yaniv M. The transactivation potential of variant hepatocyte nuclear factor 1 is modified by alternative splicing. J. Biol. Chem.268(34), 25706–25711 (1993).
   PubMed Web of Science ®Google Scholar
• Haumaitre C, Reber M, Cereghini S. Functions of HNF1 family members in differentiation of the visceral endoderm cell lineage. J. Biol. Chem.278(42), 40933–40942 (2003).
   PubMedGoogle Scholar
• Rodolosse A, Carriere V, Rousset M, Lascasa M. Two HNF-1 binding sites govern the glucose repression of the human sucrase-isomaltase promoter. Biochem. J.336, 115–123 (1998).
   PubMedGoogle Scholar
• Gu N, Suzuki N, Takeda J et al. Effect of mutations in HNF-1α and HNF-1β on the transcriptional regulation of human sucrase-isomaltase in Caco-2 cells. Biochem. Biophys. Res. Commun.325(1), 308–313 (2004).
   PubMed Web of Science ®Google Scholar
• Romero L, Ng L, Kirby G. Chemical inducers of rodent glutathione s-transferases down-regulate human GSTA1 transcription through a mechanism involving variant hepatic nuclear factor 1-C. Mol. Pharmacol.70(1), 277–286 (2006).
   PubMed Web of Science ®Google Scholar
• Hansen SK, Parrizas M, Jensen ML et al. Genetic evidence that HNF-1α-dependent transcriptional control of HNF-4α is essential for human pancreatic β cell function. J. Clin. Invest.110(6), 827–833 (2002).
   PubMed Web of Science ®Google Scholar
• Eeckhoute J, Moerman E, Bouckenooghe T et al. Hepatocyte nuclear factor 4α isoforms originated from the P1 promoter are expressed in human pancreatic β-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms. Endocrinology144(5), 1686–1694 (2003).
   PubMed Web of Science ®Google Scholar
• Sladek FM, Ruse MD Jr, Nepomuceno L, Huang SM, Stallcup MR. Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4a1. Mol. Cell. Biol.19(10), 6509–6522 (1999).
   PubMed Web of Science ®Google Scholar
• Jiang S, Tanaka T, Iwanari H et al. Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4α (HNF4α) isoforms in human and rats. Nuclear Receptor1, 5–17 (2003).
   PubMedGoogle Scholar
• Ihara A, Yamagata K, Nammo T et al. Functional characterization of the HNF4α isoform (HNF4α8) expressed in pancreatic β-cells. Biochem. Biophys. Res. Commun.329(3), 984–990 (2005).
   Google Scholar
• Nakhei H, Lingott A, Lemm I, Ryffel GU. An alternative splice variant of the tissue specific transcription factor HNF4α predominates in undifferentiated murine cell types. Nucleic Acids Res.26(2), 497–504 (1998).
   PubMedGoogle Scholar
• Thomas H, Jaschkowitz K, Bulman M et al. A distant upstream promoter of the HNF-4α gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum. Mol. Genet.10(19), 2089–2097 (2001).
   PubMed Web of Science ®Google Scholar
• Hata S, Tsukamoto T, Osumi T. A novel isoform of rat hepatocyte nuclear factor 4 (HNF-4). Biochim. Biophys. Acta1131(2), 211–213 (1992).
   PubMedGoogle Scholar
• Odom DT, Zizlsperger N, Gordon DB et al. Control of pancreas and liver gene expression by HNF transcription factors. Science303(5662), 1378–1381 (2004).
   PubMed Web of Science ®Google Scholar
• Bailly A, Torres-Padilla ME, Tinel AP, Weiss MC. An enhancer element 6 kb upstream of the mouse HNF4α1 promoter is activated by glucocorticoids and liver-enriched transcription factors. Nucleic Acids Res.29(17), 3495–3505 (2001).
   PubMedGoogle Scholar
• Torres-Padilla ME, Fougere-Deschatrette C, Weiss MC. Expression of HNF4α isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3´ end splicing. Mech. Dev.109(2), 183–193 (2001).
   PubMed Web of Science ®Google Scholar
• Briancon N, Bailly A, Clotman F, Jacquemin P, Lemaigre FP, Weiss MC. Expression of the α7 isoform of hepatocyte nuclear factor (HNF) 4 is activated by HNF6/OC-2 and HNF1 and repressed by HNF4α1 in the liver. J. Biol. Chem.279(32), 33398–33408 (2004).
   PubMedGoogle Scholar
• Suaud L, Joseph B, Formstecher P, Laine B. mRNA expression of HNF-4 isoforms and of HNF-1α/HNF-1β variants and differentiation of human cell lines that mimic highly specialized phenotypes of intestinal epithelium. Biochem. Biophys. Res. Commun.235(3), 820–825 (1997).
   PubMedGoogle Scholar
• Runge D, Runge D, Daskalakis N, Lubecki K, Bowen W, Michalopoulos G. Matrix-mediated changes in the expression of HNF-4α isoforms and in DNA-binding activity of ARP-1 in primary cultures of rat hepatocytes. Biochem. Biophys. Res. Commun.259(3), 651–655 (1999).
   Google Scholar
• Harries LW, Hattersley AT, Ellard S. Messenger RNA transcripts of the hepatocyte nuclear factor-1α gene containing premature termination codons are subject to nonsense-mediated decay. Diabetes53(2), 500–504 (2004).
   Google Scholar
• Thomas H, Badenberg B, Bulman M et al. Evidence for haploinsufficiency of the HNF1α gene revealed by functional characterisation of MODY3-associated mutations. Biol. Chem.383(11), 1691–1700 (2002).
   Google Scholar
• Bulman MP, Harries LW, Hansen T et al. Abnormal splicing of hepatocyte nuclear factor 1α in maturity-onset diabetes of the young. Diabetologia45(10), 1463–1467 (2002).
   Google Scholar
• Harries LW, Ellard S, Jones RW, Hattersley AT, Bingham C. Abnormal splicing of hepatocyte nuclear factor-1β in the renal cysts and diabetes syndrome. Diabetologia47(5), 937–942 (2004).
   Google Scholar
• Harries LW, Bingham C, Bellanne-Chantelot C, Hattersley AT, Ellard S. The position of premature termination codons in the hepatocyte nuclear factor -1β gene determines susceptibility to nonsense-mediated decay. Hum. Genet.118(2), 214–224 (2005).
   Google Scholar
• Bingham C, Hattersley AT. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1β. Nephrol Dial. Transplant.19(11), 2703–2708 (2004).
   PubMed Web of Science ®Google Scholar
• Edghill E, Bingham C, Ellard S, Hattersley A. Mutations in hepatocyte nuclear factor-1β and their related phenotypes. J. Med. Genet.43(1), 84–90 (2006).
   PubMed Web of Science ®Google Scholar
• Barbacci E, Reber M, Ott M-O, Breillat C, Huetz F, Cereghini S. Variant hepatocyte nuclear factor1 is required for visceral endoderm specification. Development126, 4795–4805 (1999).
   PubMed Web of Science ®Google Scholar
• Coffinier C, Barra J, Babinet C, Yaniv M. Expression of the vHNF1/HNF1β homeoprotein gene during mouse organogenesis. Mech. Dev.89(1–2), 211–213 (1999).
   PubMed Web of Science ®Google Scholar
• Briancon N, Weiss M. In vivo role of the HNF4α AF-1 activation domain revealed by exon swapping. EMBO J.25(6), 1253–1262 (2006).
   Google Scholar
• Ek J, Hansen S, Lajer M et al. A novel -192c/g mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4α gene (HNF4A) associates with late-onset diabetes. Diabetes55(6), 1869–1873 (2006).
   Google Scholar
• Raeder H, Bjorkhaug L, Johansson S et al. A hepatocyte nuclear factor-4α gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the norwegian MODY registry. Diabetes55(6), 1899–1903 (2006).
   Google Scholar
• Damcott C, Hoppman N, Ott S et al. Polymorphisms in both promoters of hepatocyte nuclear factor 4-α are associated with Type 2 diabetes in the Amish. Diabetes53(12), 337–341 (2004).
   Google Scholar
• Silander K, Mohlke KL, Scott L et al. Genetic variation near the hepatocyte nuclear factor-4 α gene predicts susceptibility to type 2 diabetes. Diabetes53(4), 1141–1149 (2004).
   PubMed Web of Science ®Google Scholar
• Love-Gregory L, Wasson J, Ma J, Jin CH, Suarez BK, Permutt MA. A common polymorphism in the upstream promoter (P2) of the HNF4α gene on chromosome 20q is associated with Type 2 diabetes (T2DM) and appears to account for the evidence for linkage in an Ashkenazi Jewish population. Am. J. Hum. Genet.73(5), 534 (2003).
   Google Scholar
• Hara K, Horikoshi M, Kitazato H et al. Hepatocyte nuclear factor-4α P2 promoter haplotypes are associated with Type 2 diabetes in the Japanese population. Diabetes55(5), 1260–1264 (2006).
   Google Scholar
• Weissglas-Volkov D, Huertas-Vasquez A, Suviolahti E et al. Common hepatic nuclear factor-4α variants are associated with high serum lipid levels and the metabolic syndrome. Diabetes55(7), 1970–1977 (2006).
   Google Scholar
• Bluteau O, Jeannot F, Bioulac-Sage P et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat. Genetics32(2), 312–315 (2002).
   PubMed Web of Science ®Google Scholar
• Terasawa K, Toyota M, Sagae S et al. Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines. Br. J. Cancer94(6), 914–921 (2006).
   PubMed Web of Science ®Google Scholar
• Rebouissou S, Vasiliu V, Thomas C et al. Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas. Hum. Mol. Genet.14(5), 603–614 (2005).
   PubMed Web of Science ®Google Scholar
• Lazarevich N, Cheremnova O, Varga E et al. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology39(4), 1038–1047 (2004).
   PubMed Web of Science ®Google Scholar
• Byrne MM, Sturis J, Fajans SS et al. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes44(6), 699–704 (1995).
   PubMed Web of Science ®Google Scholar
• Byrne MM, Sturis J, Menzel S et al. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes45, 1503–1510 (1996).
   PubMed Web of Science ®Google Scholar
• Jones J, Shepherd M, Ellard S, Hattersley A, Steele A, Pearson ER. Macrosomia and neonatal hypoglycaemia can be seen in the offspring of fathers with diabetes. Diabetic Medicine23(Suppl. 2), A17 (2006).
   Google Scholar
• Pontoglio M, Barra J, Hadchouel M et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal fanconi syndrome. Cell84, 575–585 (1996).
   PubMed Web of Science ®Google Scholar
• Pontoglio M, Sreenan S, Roe M et al. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J. Clin.101(10), 2215–2222 (1998).
   Google Scholar
• Dukes ID, Sreenan S, Roe MW et al. Defective pancreatic β-cell glycolytic signaling in hepatocyte nuclear factor-1α-deficient mice. J. Biol. Chem.273(38), 24457–24464 (1998).
   PubMed Web of Science ®Google Scholar
• Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1α (HNF-1α) and 4α (HNF-4α) in maturity-onset diabetes of the young. Mutation Res.27, 854–869 (2006).
   Google Scholar
• Yamagata K, Yang Q, Yamamoto K et al. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1 α is dominant negative. Diabetes47(8), 1231–1235 (1998).
   PubMedGoogle Scholar
• Frayling TM, Evans JC, Bulman MP et al. β-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes50(Suppl. 1), S94–S100 (2001).
   PubMed Web of Science ®Google Scholar
• Mattick J, Makunin IV. Small regulatory RNAs in mammals. Hum. Mol. Genet. Spec No 1, R121–R132 (2005).
   Google Scholar
• Welters H, Senkel S, Klein-Hitpass L et al. HNF1B , the candidate gene product for MODY5, regulates the viability and functional competence of pancreatic cells. J. Endocrinology190, 171–181 (2006).
   PubMed Web of Science ®Google Scholar
• Sumanas S, Larson J. Morpholino phosphorodiamidate oligonucleotides in zebrafish: a recipe for functional genomics? Brief Funct. Genomic Proteomic.1(3), 239–256 (2002).
   Google Scholar
• McClorey G, Moulton H, Iversen P, Fletcher S, Wilton S. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Therapy13(19), 1373–1381 (2006).
   PubMed Web of Science ®Google Scholar
• McCaffrey A, Meuse L, Karimi M, Contag C, Kay M. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice. Hepatology38(2), 503–508 (2003).
   PubMed Web of Science ®Google Scholar
• Kipshidze N, Tsapenko M, Iversen P, Burger D. Antisense therapy for restenosis following percutaneous coronary intervention. Expert Opin. Biol. Ther.5(1), 79–89 (2005).
   PubMed Web of Science ®Google Scholar
• Shih DQ, Screenan S, Munoz KN et al. Loss of HNF-1α function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes50(11), 2472–2480 (2001).
   PubMed Web of Science ®Google Scholar
• Shih D, Heimesaat M, Kuwajima S, Stein R, Wright C, Stoffel M. Profound defects in pancreatic β-cell function in mice with combined heterozygous mutations in Pdx-1, HNF-1α and HNF-3β. Proc. Natl. Acad. Sci. USA99, 3818–3823 (2002).
   PubMed Web of Science ®Google Scholar
• Shih DQ, Dansky HM, Fleisher M, Assmann G, Fajans SS, Stoffel M. Genotype/phenotype relationships in HNF-4α/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes49(5), 832–837 (2000).
   PubMed Web of Science ®Google Scholar
• Stoffel M, Duncan SA. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolism. Proc. Natl Acad. Sci. USA94(24), 13209–13214 (1997).
   PubMed Web of Science ®Google Scholar
• Wang L, Coffinier C, Thomas M et al. Selective deletion of the HNF1B (MODY5) gene in B-cells leads to altereed gene expression and defective insulin release. Endocrinology145(8), 3941–3949 (2004).
   PubMed Web of Science ®Google Scholar
• Sun Z, Hopkins N. vHNF-1, the MODY5 and familial GCKD-assoxiated gene regulates regional specification of the zebrafish gut, pronephros and hindbrain. Genes Dev.15, 3217–3229 (2001).
   PubMed Web of Science ®Google Scholar
• Gerrish K, Cissell MA, Stein R. The role of hepatic nuclear factor 1α and PDX-1 in transcriptional regulation of the pdx-1 gene. J. Biol. Chem.276(51), 47775–47784 (2001).
   PubMedGoogle Scholar